🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Researchers are evaluating the safety and effectiveness of a single adminis...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2019-10-30
Trial ID
NCT04176133
Treatments Being Tested
The overall aim of this project is to evaluate the immunogenicity of TIV va...
Status
Completed
Location
Nrf/Dst Vpd Rmpru
Start Date
2013-05
Trial ID
NCT01812980
Treatments Being Tested
Adopt the design of random, blind method and placebo to parallel control an...
Status
Completed
Location
Multiple Locations
Start Date
2015-11-06
Trial ID
NCT03196661
Treatments Being Tested
This is a Phase I double-blind, randomized, placebo-controlled study in 50 ...
Status
Completed
Location
Saint Louis University - Center for Vaccine Development
Start Date
2018-08-15
Trial ID
NCT03553940
The aim of this study is to assess the immunogenicity, safety and reactogen...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-10-14
Trial ID
NCT05568797
Treatments Being Tested
This unblinded pilot study is intended to assess the feasibility of a large...
Status
Completed
Location
Mount Sinai Hospital
Start Date
2008-11
Trial ID
NCT00784784
The study is a single centre, phase I, double-blind, randomized, placebo-co...
Status
Completed
Location
Kazakh National Medical University
Start Date
2016-05
Trial ID
NCT03028116
Treatments Being Tested
This study includes 3 parts: Parts A, B, and C. The purpose of this study i...
Status
Completed
Location
Pinnacle Research Group
Start Date
2023-04-17
Trial ID
NCT05827978
Treatments Being Tested
The purpose of this study is to describe extra-pulmonary clinical manifesta...
Status
Completed
Location
CHU de Poitiers
Start Date
2018-12-03
Trial ID
NCT03757546
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity, safety, and re...
Status
Completed
Location
Pinnacle Research Group-409 E 10th St
Start Date
2023-10-19
Trial ID
NCT06097273
Treatments Being Tested